National HIV CurriculumLogo

HIV Clinical Care Question Bank

Evaluation and Management of Virologic FailureQuestion 7/10

A 55-year-old woman is seen in a clinic for a follow-up evaluation. Her HIV RNA level has been suppressed for several years while taking bictegravir-tenofovir alafenamide-emtricitabine. During the last 2 years, she has gained about 15 to 20 pounds. In the past, she took efavirenz-tenofovir DF-emtricitabine and on this regimen had virologic failure; drug-resistant genotype results showed the following reverse transcriptase mutations: Y188L, K103N, M184V, and G190A. Because of the weight gain, there is a consideration for switching the current antiretroviral regimen to doravirine-tenofovir DF-emtricitabine.

Based on the drug-resistance genotype result, do these mutations indicate drug resistance to doravirine?

Figure 1. Impact of Reverse Transcriptase Mutations on Doravirine
Source: Stanford University HIV Drug Resistance Database
Illustration: David H. Spach, MD
Figure 2. Doravirine Resistance Pathways
Source: Feng M, Wang D, Grobler JA, Hazuda DJ, Miller MD, Lai MT. In vitro resistance selection with doravirine (MK-1439), a novel nonnucleoside reverse transcriptase inhibitor with distinct mutation development pathways. Antimicrob Agents Chemother. 2015;59:590-8.
Prev  Skip

Sign In or Register Progress Not Saved!
Since you are not signed in, your progress won't be saved.
Question Last Updated
January 28th, 2025

Steps to acquire a Certificate for this Lesson:

1

Answer Questions

Answer the board-review style questions
2

Answer Correctly

Score 80% on questions
3

Give Feedback

Complete survey
4

Print Certificate

Document work

This question requires improvement because:


Comment further on how to improve this question or summary:



The Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS) provided financial support for this website. The award provided 100% of total costs and totaled $1,175,136. The contents are those of the author. They may not reflect the policies of HRSA, HHS, or the U.S. Government.

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.